Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy

Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy

Natural killer (NK) cells have recently gained popularity as an alternative for cancer immunotherapy. Adoptive cell transfer employing NK cells offers a safer therapeutic option compared to T-cell-based therapies, due to their significantly lower toxicity and the availability of diverse autologous a...

Full description

Bibliographic Details
Main Authors: Stefania Douka, Vasilis Papamoschou, Monica Raimo, Enrico Mastrobattista, Massimiliano Caiazzo
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Pharmaceutics
Subjects:
cancer immunotherapy
adoptive cell transfer
NK cells
tumor microenvironment
receptor engineering
NK cell clinical trials
Online Access:https://www.mdpi.com/1999-4923/16/9/1143

Internet

https://www.mdpi.com/1999-4923/16/9/1143

Similar Items